Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,576.40
(
1.26%
)
Dow Jones
45,577.47
(
0.00%
)
Brent Oil
100.48
(
-7.08%
)
Bitcoin
70,280.30
(
3.59%
)
News Focus
News Focus
Post# of 4101
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Monday, 12/15/2003 11:33:10 PM

Monday, December 15, 2003 11:33:10 PM

Post# of 4101
What’s up with RGEN?

Walter says the first phase-3 Secretin trial is complete by now, but the company will not unblind the data until Jan. 5. Should this be accepted at face value?

The stock is behaving as though someone expects the data to be less than stellar.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today